These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22738696)

  • 1. Comparison between symptomatic treatment and lomustine supplementation in 71 dogs with intracranial, space-occupying lesions.
    Van Meervenne S; Verhoeven PS; de Vos J; Gielen IM; Polis I; Van Ham LM
    Vet Comp Oncol; 2014 Mar; 12(1):67-77. PubMed ID: 22738696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: A comparative retrospective study (2008-2017).
    Moirano SJ; Dewey CW; Wright KZ; Cohen PW
    Vet Comp Oncol; 2018 Dec; 16(4):459-466. PubMed ID: 29797768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
    Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
    J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors.
    Hosoya K; Kisseberth WC; Alvarez FJ; Lara-Garcia A; Beamer G; Stromberg PC; Couto CG
    J Am Anim Hosp Assoc; 2009; 45(1):14-8. PubMed ID: 19122059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case of a miniature dachshund with a primitive neuroectodermal tumor confined to the forebrain region treated with a combination of surgery and chemotherapy.
    Nakamoto Y; Yamada A; Uchida K; Matsunaga S; Ozawa T
    J Vet Med Sci; 2016 Dec; 78(11):1703-1707. PubMed ID: 27430318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of metronomic administration of lomustine in dogs with cancer.
    Tripp CD; Fidel J; Anderson CL; Patrick M; Pratt C; Sellon R; Bryan JN
    J Vet Intern Med; 2011; 25(2):278-84. PubMed ID: 21314727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary study of lomustine in the treatment of intracranial masses in dogs following localization by imaging techniques.
    Fulton LM; Steinberg HS
    Semin Vet Med Surg Small Anim; 1990 Nov; 5(4):241-5. PubMed ID: 2075303
    [No Abstract]   [Full Text] [Related]  

  • 8. Lomustine for the treatment of gastrointestinal mast cell tumour in a dog.
    Baldi A; Colloca E; Spugnini EP
    J Small Anim Pract; 2006 Aug; 47(8):465-7. PubMed ID: 16911116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
    Heading KL; Brockley LK; Bennett PF
    Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers.
    Elliott J
    Aust Vet J; 2018 Dec; 96(12):502-507. PubMed ID: 30478839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic.
    Laprais A; Olivry T
    BMC Vet Res; 2017 Feb; 13(1):61. PubMed ID: 28222789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple cutaneous histiocytomas treated with lomustine in a dog.
    Maina E; Colombo S; Stefanello D
    Vet Dermatol; 2014 Dec; 25(6):559-62, e98-9. PubMed ID: 24963782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervicothoracic syringohydromyelia associated with a prosencephalic mass in a dog.
    Szabo D; Saveraid TC; Rodenas S
    J Small Anim Pract; 2012 Oct; 53(10):613-7. PubMed ID: 23013378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oral administration of lomustine and prednisolone or prednisolone alone as treatment for granulomatous meningoencephalomyelitis or necrotizing encephalitis in dogs.
    Flegel T; Boettcher IC; Matiasek K; Oevermann A; Doherr MG; Oechtering G; Henke D
    J Am Vet Med Assoc; 2011 Feb; 238(3):337-45. PubMed ID: 21281217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.
    Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL
    J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomic administration of lomustine following palliative radiation therapy for appendicular osteosarcoma in dogs.
    Duffy ME; Anderson CL; Choy K; Fidel JL
    Can Vet J; 2018 Feb; 59(2):136-142. PubMed ID: 29386671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy.
    Mason SL; Finotello R; Blackwood L
    Vet Comp Oncol; 2018 Mar; 16(1):E30-E37. PubMed ID: 28621004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs.
    Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE
    J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of canine mast cell tumors with CCNU (lomustine).
    Rassnick KM; Moore AS; Williams LE; London CA; Kintzer PP; Engler SJ; Cotter SM
    J Vet Intern Med; 1999; 13(6):601-5. PubMed ID: 10587263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.
    Burton JH; Venable RO; Vail DM; Williams LE; Clifford CA; Axiak-Bechtel SM; Avery AC; Thamm DH
    J Vet Intern Med; 2015; 29(4):1098-104. PubMed ID: 26119008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.